1 |
Baldessarini RJ, Tarazi FI. 2005. Pharmacotherapy of psychosis and mania. pp. 461-500. In: Brunton LL, Lazo JS, Parker KL (ed.). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th ed. McGrawHill, New York.
|
2 |
Barnhart MD, Hubbell JAE, Muir WW. 2000. Evaluation of the analgesic properties of acepromazine maleate, oxymorphone, medetomidine and a combination of acepromazine-oxymorphone. Vet Anaesth Analg 27: 89-96.
DOI
|
3 |
Bergadano A, Andersen OK, Arendt-Nielsen L, Spadavecchia C. 2009. Modulation of nociceptive withdrawal reflexes evoked by single and repeated nociceptive stimuli in conscious dogs by low-dose acepromazine. Vet Anaesth Analg 36: 261-272.
DOI
|
4 |
Bleijenberg EH, van Oostrom H, Akkerdaas LC, Doornenbal A, Hellebrekers LJ. 2011. Bispectral index and the clinically evaluated anaesthetic depth in dogs. Vet Anaesth Analg 38: 536-543.
DOI
|
5 |
Boyd CJ, McDonell WN, Valliant A. 1991. Comparative hemodynamic effects of halothane and halothane-acepromazine at equipotent doses in dogs. Can J Vet Res 55: 107-112.
|
6 |
Cullen LK. 1999. Xylazine and medetomidine in small animals: these drugs should be used carefully. Aust Vet J 77: 722-723.
DOI
|
7 |
Dyson DH, Maxie MG, Schnurr D. 1998. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc 34: 325-335.
DOI
|
8 |
Ferre PJ, Pasloske K, Whittem T, Ranasinghe MG, Li Q, Lefebvre HP. 2006. Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. Vet Anaesth Analg 33: 229-236.
DOI
|
9 |
Greene SA. 1999. Pros and cons of using alpha-2 agonists in small animal anesthesia practice. Clin Tech Small Anim Pract 14: 10-14.
DOI
|
10 |
Hall LW, Clarke KW, Trim CM. 2001. Veterinary anaesthesia. pp. 561. 10th ed. Saunders.New York.
|
11 |
Hall TL, Duke T, Townsend HG, Caulkett NA, Cantwell SL. 1999. The effect of opioid and acepromazine premedication on the anesthetic induction dose of propofol in cats. Can Vet J 40: 867-870.
|
12 |
Herbert GL, Bowlt KL, Ford-Fennah V, Covey-Crump GL, Murrell JC. 2012. Alfaxalone for total intravenous anaesthesia in dogs undergoing ovariohysterectomy: a comparison of premedication with acepromazine or dexmedetomidine. Vet Anaesth Analg 40: 124-133.
|
13 |
Montgomery GH, DuHamel KN, Redd WH. 2000. A meta-analysis of hypnotically induced analgesia: how effective is hypnosis Int J Clin Exp Hypn 48: 138-153.
DOI
|
14 |
Ilback NG, Stalhandske T. 2003. Cardiovascular effects of xylazine recorded with telemetry in the dog. J Vet Med A Physiol Pathol Clin Med 50: 479-483.
DOI
|
15 |
Lemke KA. 2004. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can Vet J 45: 475-480.
|
16 |
Lukasik VM, Gillies RJ. 2003. Animal anaesthesia for in vivo magnetic resonance. NMR Biomed 16: 459-467.
DOI
|
17 |
Murrell J. 2007. Choice of premedicants in cats and dogs. In Practice 29: 100-106.
DOI
|
18 |
Popovic NA, Mullane JF, Yhap EO. 1972. Effects of acetylpromazine maleate on certain cardiorespiratory responses in dogs. Am J Vet Res 33: 1819-1824.
|
19 |
Singh H. 1999. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. Eur J Anaesthesiol 16: 31-36.
DOI
|
20 |
Suarez MA, Dzikiti BT, Stegmann FG, Hartman M. 2012. Comparison of alfaxalone and propofol administered as total intravenous anaesthesia for ovariohysterectomy in dogs. Vet Anaesth Analg 39: 236-244.
DOI
|
21 |
Tranquilli WJ, Benson GJ. 1992. Advantages and guidelines for using alpha-2 agonists as anesthetic adjuvants. Vet Clin North Am Small Anim Pract 22: 289-293.
DOI
|
22 |
Turner DM, Ilkiw JE, Rose RJ, Warren JM. 1974. Respiratory and cardiovascular effects of five drugs used as sedatives in the dog. Aust Vet J 50: 260-265.
DOI
|